Education
About Us
Working with TipRanks
Follow Us
Ascentage Pharma Group International (HK:6855)
:6855
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
6855 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
HK$78
Hold
0.06%
Upside
Reiterated
06/26/25
J.P. Morgan
HK$52
Buy
-33.29%
Downside
Initiated
03/26/25
Citi
HK$41→HK$52
Buy
-33.29%
Downside
Reiterated
12/05/24
Jefferies
HK$36→HK$40
Buy
-48.69%
Downside
Reiterated
08/27/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
HK$78
Hold
0.06%
Upside
Reiterated
06/26/25
J.P. Morgan
HK$52
Buy
-33.29%
Downside
Initiated
03/26/25
Citi
HK$41→HK$52
Buy
-33.29%
Downside
Reiterated
12/05/24
Jefferies
HK$36→HK$40
Buy
-48.69%
Downside
Reiterated
08/27/24
Best Analysts Covering Ascentage Pharma Group International
1 Month
xxx
Success Rate
1/3 ratings generated profit
Average Return
+1.97%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +1.97% per trade.
3 Months
xxx
Success Rate
2/3 ratings generated profit
Average Return
+12.17%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +12.17% per trade.
1 Year
2 Years
xxx
Success Rate
3/3 ratings generated profit
Average Return
+142.13%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +142.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
6855 Analyst Recommendation Trends
Rating
Aug 23
Aug 24
Dec 24
Mar 25
Jun 25
Strong Buy
0
0
0
0
0
Buy
2
3
4
3
2
Hold
0
0
0
0
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
3
4
3
6
Each month's total comprises the sum of three months' worth of ratings.
6855 Stock Forecast FAQ
What is HK:6855’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascentage Pharma Group International’s 12-month average price target is 73.00.
What is HK:6855’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:6855, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ascentage Pharma Group International a Buy, Sell or Hold?
Ascentage Pharma Group International has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Ascentage Pharma Group International’s share price target?
The average share price target for Ascentage Pharma Group International is 73.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$73.00 ,and the lowest forecast is HK$73.00. The average share price target represents -6.35% Decrease from the current price of HK$77.95.
The highest analyst share price target is HK$73.00 ,and the lowest forecast is HK$73.00. The average share price target represents -6.35% Decrease from the current price of HK$77.95.
What do analysts say about Ascentage Pharma Group International?
Ascentage Pharma Group International’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Ascentage Pharma Group International?
To buy shares of HK:6855, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.